Same Indication

Nivolumab vs Valsartan

Nivolumab vs Valsartan: Overview

This comparison examines the pharmacological differences between Nivolumab and Valsartan.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Valsartan: Angiotensin II type 1 receptor blocker.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Valsartan β€” 6 hours.

Chemical Properties

Molecular Formula: Valsartan β€” C24H29N5O3.

Molecular Weight: Valsartan β€” 435.5190 g/mol.

Type: Nivolumab β€” Antibody; Valsartan β€” Small molecule.